Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Household Gun Ownership and Youth Suicide Rates at the State Level, 2005-2015.

Knopov A, Sherman RJ, Raifman JR, Larson E, Siegel MB.

Am J Prev Med. 2019 Mar;56(3):335-342. doi: 10.1016/j.amepre.2018.10.027. Epub 2019 Jan 17.

PMID:
30661885
2.

Generalized bullous fixed-drug eruption secondary to the influenza vaccine.

Byrd RC, Mournighan KJ, Baca-Atlas M, Helton MR, Sun NZ, Siegel MB.

JAAD Case Rep. 2018 Oct 12;4(9):953-955. doi: 10.1016/j.jdcr.2018.07.013. eCollection 2018 Oct. No abstract available.

3.

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.

Van Swearingen AED, Siegel MB, Deal AM, Sambade MJ, Hoyle A, Hayes DN, Jo H, Little P, Dees EC, Muss H, Jolly T, Zagar TM, Patel N, Miller CR, Parker JS, Smith JK, Fisher J, Shah N, Nabell L, Nanda R, Dillon P, Abramson V, Carey LA, Anders CK.

Breast Cancer Res Treat. 2018 Oct;171(3):637-648. doi: 10.1007/s10549-018-4852-5. Epub 2018 Jun 25.

PMID:
29938395
4.

A multi-decade joinpoint analysis of firearm injury severity.

Kalesan B, Zuo Y, Xuan Z, Siegel MB, Fagan J, Branas C, Galea S.

Trauma Surg Acute Care Open. 2018 Feb 13;3(1):e000139. doi: 10.1136/tsaco-2017-000139. eCollection 2018.

5.

Electronic Cigarette Prevalence and Patterns of Use in Adults with a History of Cardiovascular Disease in the United States.

Stokes A, Collins JM, Berry KM, Reynolds LM, Fetterman JL, Rodriguez CJ, Siegel MB, Benjamin EJ.

J Am Heart Assoc. 2018 Apr 26;7(9). pii: e007602. doi: 10.1161/JAHA.117.007602.

6.

E-cigarette initiation and associated changes in smoking cessation and reduction: the Population Assessment of Tobacco and Health Study, 2013-2015.

Berry KM, Reynolds LM, Collins JM, Siegel MB, Fetterman JL, Hamburg NM, Bhatnagar A, Benjamin EJ, Stokes A.

Tob Control. 2019 Jan;28(1):42-49. doi: 10.1136/tobaccocontrol-2017-054108. Epub 2018 Mar 24.

7.

Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer.

Siegel MB, He X, Hoadley KA, Hoyle A, Pearce JB, Garrett AL, Kumar S, Moylan VJ, Brady CM, Van Swearingen AE, Marron D, Gupta GP, Thorne LB, Kieran N, Livasy C, Mardis ER, Parker JS, Chen M, Anders CK, Carey LA, Perou CM.

J Clin Invest. 2018 Apr 2;128(4):1371-1383. doi: 10.1172/JCI96153. Epub 2018 Feb 26.

8.

Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma.

Connolly NP, Shetty AC, Stokum JA, Hoeschele I, Siegel MB, Miller CR, Kim AJ, Ho CY, Davila E, Simard JM, Devine SE, Rossmeisl JH, Holland EC, Winkles JA, Woodworth GF.

Sci Rep. 2018 Jan 19;8(1):1180. doi: 10.1038/s41598-018-19451-6.

9.

Modified HyperCVAD Versus Bortezomib-HyperCAD in Patients With Relapsed/Refractory Multiple Myeloma.

Saraceni MM, Scott E, Maziarz RT, Siegel MB, Bassale S, Jiing S, Medvedova E.

Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e77-e84. doi: 10.1016/j.clml.2017.10.008. Epub 2017 Nov 2.

PMID:
29169873
10.

Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.

Williams EC, Achtmeyer CE, Young JP, Berger D, Curran G, Bradley KA, Richards J, Siegel MB, Ludman EJ, Lapham GT, Forehand M, Harris AHS.

J Gen Intern Med. 2018 Mar;33(3):258-267. doi: 10.1007/s11606-017-4202-z. Epub 2017 Oct 30.

11.

The Difficult Transition.

Siegel MB.

JAMA Oncol. 2017 Dec 1;3(12):1626-1627. doi: 10.1001/jamaoncol.2017.2669. No abstract available.

PMID:
28910437
12.

Positive and negative affect following marijuana use in naturalistic settings: An ecological momentary assessment study.

Ross CS, Brooks DR, Aschengrau A, Siegel MB, Weinberg J, Shrier LA.

Addict Behav. 2018 Jan;76:61-67. doi: 10.1016/j.addbeh.2017.07.020. Epub 2017 Jul 15. No abstract available.

PMID:
28756041
13.

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.

Kodack DP, Askoxylakis V, Ferraro GB, Sheng Q, Badeaux M, Goel S, Qi X, Shankaraiah R, Cao ZA, Ramjiawan RR, Bezwada D, Patel B, Song Y, Costa C, Naxerova K, Wong CSF, Kloepper J, Das R, Tam A, Tanboon J, Duda DG, Miller CR, Siegel MB, Anders CK, Sanders M, Estrada MV, Schlegel R, Arteaga CL, Brachtel E, Huang A, Fukumura D, Engelman JA, Jain RK.

Sci Transl Med. 2017 May 24;9(391). pii: eaal4682. doi: 10.1126/scitranslmed.aal4682. Erratum in: Sci Transl Med. 2019 Jan 30;11(477):.

14.

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.

Van Swearingen AED, Sambade MJ, Siegel MB, Sud S, McNeill RS, Bevill SM, Chen X, Bash RE, Mounsey L, Golitz BT, Santos C, Deal A, Parker JS, Rashid N, Miller CR, Johnson GL, Anders CK.

Neuro Oncol. 2017 Oct 19;19(11):1481-1493. doi: 10.1093/neuonc/nox052.

15.

Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma.

Vitucci M, Irvin DM, McNeill RS, Schmid RS, Simon JM, Dhruv HD, Siegel MB, Werneke AM, Bash RE, Kim S, Berens ME, Miller CR.

Neuro Oncol. 2017 Sep 1;19(9):1237-1247. doi: 10.1093/neuonc/nox050.

16.

SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling.

Silva GO, Siegel MB, Mose LE, Parker JS, Sun W, Perou CM, Chen M.

Genome Biol. 2017 Apr 8;18(1):66. doi: 10.1186/s13059-017-1193-3.

17.

Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.

McNeill RS, Canoutas DA, Stuhlmiller TJ, Dhruv HD, Irvin DM, Bash RE, Angus SP, Herring LE, Simon JM, Skinner KR, Limas JC, Chen X, Schmid RS, Siegel MB, Van Swearingen AED, Hadler MJ, Sulman EP, Sarkaria JN, Anders CK, Graves LM, Berens ME, Johnson GL, Miller CR.

Neuro Oncol. 2017 Oct 19;19(11):1469-1480. doi: 10.1093/neuonc/nox044.

18.

The Hidden Epidemic of Firearm Injury: Increasing Firearm Injury Rates During 2001-2013.

Kalesan B, Adhikarla C, Pressley JC, Fagan JA, Xuan Z, Siegel MB, Galea S.

Am J Epidemiol. 2017 Apr 1;185(7):546-553. doi: 10.1093/aje/kww147.

PMID:
28338922
19.

Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation.

Kechele DO, Blue RE, Zwarycz B, Espenschied ST, Mah AT, Siegel MB, Perou CM, Ding S, Magness ST, Lund PK, Caron KM.

J Clin Invest. 2017 Feb 1;127(2):593-607. doi: 10.1172/JCI87588. Epub 2017 Jan 17.

20.

Correction: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases.

Hoadley KA, Siegel MB, Kanchi KL, Miller CA, Ding L, Zhao W, He X, Parker JS, Wendl MC, Fulton RS, Demeter RT, Wilson RK, Carey LA, Perou CM, Mardis ER.

PLoS Med. 2017 Jan 9;14(1):e1002222. doi: 10.1371/journal.pmed.1002222. eCollection 2017 Jan.

21.

Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases.

Hoadley KA, Siegel MB, Kanchi KL, Miller CA, Ding L, Zhao W, He X, Parker JS, Wendl MC, Fulton RS, Demeter RT, Wilson RK, Carey LA, Perou CM, Mardis ER.

PLoS Med. 2016 Dec 6;13(12):e1002174. doi: 10.1371/journal.pmed.1002174. eCollection 2016 Dec. Erratum in: PLoS Med. 2017 Jan 9;14 (1):e1002222.

22.

Sponsorship of National Health Organizations by Two Major Soda Companies.

Aaron DG, Siegel MB.

Am J Prev Med. 2017 Jan;52(1):20-30. doi: 10.1016/j.amepre.2016.08.010. Epub 2016 Oct 10.

PMID:
27745783
23.

Amount of Televised Alcohol Advertising Exposure and the Quantity of Alcohol Consumed by Youth.

Naimi TS, Ross CS, Siegel MB, DeJong W, Jernigan DH.

J Stud Alcohol Drugs. 2016 Sep;77(5):723-9.

24.

Brands matter: Major findings from the Alcohol Brand Research Among Underage Drinkers (ABRAND) project.

Roberts SP, Siegel MB, DeJong W, Ross CS, Naimi T, Albers A, Skeer M, Rosenbloom DL, Jernigan DH.

Addict Res Theory. 2016;24(1):32-39. Epub 2015 Jun 4.

25.

Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma.

Siegel MB, Liu SQ, Davare MA, Spurgeon SE, Loriaux MM, Druker BJ, Scott EC, Tyner JW.

Oncotarget. 2015 Aug 7;6(22):18921-32.

26.

Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.

Zhao X, Wang A, Walter V, Patel NM, Eberhard DA, Hayward MC, Salazar AH, Jo H, Soloway MG, Wilkerson MD, Parker JS, Yin X, Zhang G, Siegel MB, Rosson GB, Earp HS 3rd, Sharpless NE, Gulley ML, Weck KE, Hayes DN, Moschos SJ.

PLoS One. 2015 Jun 15;10(6):e0129280. doi: 10.1371/journal.pone.0129280. eCollection 2015.

27.

Selection of branded alcoholic beverages by underage drinkers.

Ross CS, Ostroff J, Naimi TS, DeJong W, Siegel MB, Jernigan DH.

J Adolesc Health. 2015 May;56(5):564-70. doi: 10.1016/j.jadohealth.2015.01.018.

28.

Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.

Karginova O, Siegel MB, Van Swearingen AE, Deal AM, Adamo B, Sambade MJ, Bazyar S, Nikolaishvili-Feinberg N, Bash R, O'Neal S, Sandison K, Parker JS, Santos C, Darr D, Zamboni W, Lee YZ, Miller CR, Anders CK.

Mol Cancer Ther. 2015 Apr;14(4):920-30. doi: 10.1158/1535-7163.MCT-14-0474.

29.

Breast cancer brain metastases: evidence for neuronal-like adaptation in a 'breast-to-brain' transition?

Van Swearingen AE, Siegel MB, Anders CK.

Breast Cancer Res. 2014 May 6;16(3):304. doi: 10.1186/bcr3651.

30.

Brand preferences of underage drinkers who report alcohol-related fights and injuries.

Roberts SP, Siegel MB, DeJong W, Naimi TS, Jernigan DH.

Subst Use Misuse. 2015 Apr;50(5):619-929. doi: 10.3109/10826084.2014.997392. Epub 2015 Jan 22.

31.

Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis.

Siegel MB, Van Swearingen AE, Anders CK.

Oncology (Williston Park). 2014 Jul;28(7):579, 584-5. No abstract available.

32.

The relationships between alcohol source, autonomy in brand selection, and brand preference among youth in the USA.

Roberts SP, Siegel MB, DeJong W, Naimi TS, Jernigan DH.

Alcohol Alcohol. 2014 Sep-Oct;49(5):563-71. doi: 10.1093/alcalc/agu034. Epub 2014 Jun 12.

33.

A comparison between brand-specific and traditional alcohol surveillance methods to assess underage drinkers' reported alcohol use.

Roberts SP, Siegel MB, DeJong W, Jernigan DH.

Am J Drug Alcohol Abuse. 2014 Nov;40(6):447-54. doi: 10.3109/00952990.2014.938160. Epub 2014 Jul 25.

34.

Youth alcohol brand consumption and exposure to brand advertising in magazines.

Ross CS, Ostroff J, Siegel MB, DeJong W, Naimi TS, Jernigan DH.

J Stud Alcohol Drugs. 2014 Jul;75(4):615-22.

35.

Pilot investigation of changes in readiness and confidence to quit smoking after E-cigarette experimentation and 1 week of use.

Wagener TL, Meier E, Hale JJ, Oliver ER, Warner ML, Driskill LM, Gillaspy SR, Siegel MB, Foster S.

Nicotine Tob Res. 2014 Jan;16(1):108-14. doi: 10.1093/ntr/ntt138. Epub 2013 Oct 23.

PMID:
24154511
36.

HIF1α and HIF2α independently activate SRC to promote melanoma metastases.

Hanna SC, Krishnan B, Bailey ST, Moschos SJ, Kuan PF, Shimamura T, Osborne LD, Siegel MB, Duncan LM, O'Brien ET 3rd, Superfine R, Miller CR, Simon MC, Wong KK, Kim WY.

J Clin Invest. 2013 May;123(5):2078-93. doi: 10.1172/JCI66715. Epub 2013 Apr 8.

37.

Policy implications for familial searching.

Kim J, Mammo D, Siegel MB, Katsanis SH.

Investig Genet. 2011 Nov 1;2:22. doi: 10.1186/2041-2223-2-22.

38.

Electronic cigarettes as a smoking-cessation: tool results from an online survey.

Siegel MB, Tanwar KL, Wood KS.

Am J Prev Med. 2011 Apr;40(4):472-5. doi: 10.1016/j.amepre.2010.12.006.

PMID:
21406283
39.

Alcoholic beverage preferences and associated drinking patterns and risk behaviors among high school youth.

Siegel MB, Naimi TS, Cremeens JL, Nelson DE.

Am J Prev Med. 2011 Apr;40(4):419-26. doi: 10.1016/j.amepre.2010.12.011.

PMID:
21406275
40.

Effect of local youth-access regulations on progression to established smoking among youths in Massachusetts.

Thomson CC, Hamilton WL, Siegel MB, Biener L, Rigotti NA.

Tob Control. 2007 Apr;16(2):119-26.

41.
42.
43.

Smoking in Boston bars before and after a 100% smoke-free regulation: an assessment of early compliance.

Skeer M, Land ML, Cheng DM, Siegel MB.

J Public Health Manag Pract. 2004 Nov-Dec;10(6):501-7.

PMID:
15643372
44.

Statewide evaluation of youth access ordinances in practice: effects of the implementation of community-level regulations in Massachusetts.

Thomson CC, Gokhale M, Biener L, Siegel MB, Rigotti NA.

J Public Health Manag Pract. 2004 Nov-Dec;10(6):481-9.

PMID:
15643369
45.

California's tobacco control saga.

Novotny TE, Siegel MB.

Health Aff (Millwood). 1996 Spring;15(1):58-72.

PMID:
8920569
46.

Control of epistaxis in patients with hereditary hemorrhagic telangiectasia.

Siegel MB, Keane WM, Atkins JF Jr, Rosen MR.

Otolaryngol Head Neck Surg. 1991 Nov;105(5):675-9.

PMID:
1754250
47.

Mandibular fractures in the pediatric patient.

Siegel MB, Wetmore RF, Potsic WP, Handler SD, Tom LW.

Arch Otolaryngol Head Neck Surg. 1991 May;117(5):533-6.

PMID:
2021472
48.

Ectodermal dysplasia: the otolaryngologic manifestations and management.

Siegel MB, Potsic WP.

Int J Pediatr Otorhinolaryngol. 1990 Aug;19(3):265-71. Review.

PMID:
2210953
49.

Further experience with division of the left renal vein.

Dearing PD, James EC, Siegel MB, Swenson WM, Slotnick HB, Schmidt MJ.

Surgery. 1990 Jan;107(1):105-9.

PMID:
2296750
50.

Transsphenoidal hypophysectomy: a critical review.

Siegel MB, Hendrix RA.

Trans Pa Acad Ophthalmol Otolaryngol. 1990;42:1002-7. Review.

PMID:
2084974

Supplemental Content

Loading ...
Support Center